|
During this program, expert speakers Jugna Shah, MPH, and Valerie A. Rinkle, MPA, will analyze the proposed rule and deliver a comprehensive program to update providers on the major changes proposed for 2018, including reducing payment for drugs purchased under the 340B drug discount program, expanded packaging that includes drug administration for the first time, and new potential modifiers.
Shah and Rinkle will also review important proposals described in the Medicare Physician Fee Schedule (MPFS) proposed rule that impact outpatient hospital services, including updated payment policies for non-excepted, off-campus outpatient departments. Other proposed changes to be discussed include the inpatient-only list, skin substitute packaging, and reporting of certain clinical diagnostic laboratory tests.
|
| |
| |
At the conclusion of this program, participants will be able to: - Describe proposed changes to the 340B drug discount program and an associated new modifier
- Explain the impact of proposed packaging of low-level drug administration services
- Understand continued payment policies applicable to non-excepted, off-campus provider-based departments
- Determine the financial impact and application of CMS’ proposed modifier to identify certain imaging services
- Comment on proposals for which CMS is specifically seeking input, including reducing administrative burden, 340B program changes, and drug administration add-on code payments
|
| |
|
| |
